期刊文献+

胃黏膜肠化生细胞中胎盘型谷胱甘肽S转移酶的表达 被引量:1

Expression of Glutathione-S-transferase-π in the Gastric Mucosa with Intestinal Metaplasia
在线阅读 下载PDF
导出
摘要 目的 探讨胎盘型谷胱甘肽S转移酶 (GST π)的表达与胃黏膜肠化生及其增殖状态分型、硫酸化黏液分泌状况的关系。方法 采用免疫组织化学方法检测 16 7例胃黏膜活检及外科手术标本中GST π的表达 ,并对 112例伴肠化生慢性萎缩性胃炎作免疫组化和黏液组化套染 ,进行肠化生增殖状态分型。结果 胃腺癌、伴异型增生慢性萎缩性胃炎和伴肠化生慢性萎缩性胃炎中GST π的阳性率均显著高于慢性浅表性胃炎 ,但伴异型增生慢性萎缩性胃炎与胃腺癌中GST π的阳性率无明显差异。GST π的阳性率与肠化生细胞是否分泌硫酸黏液无关 ;高增殖型肠化生中GST π的阳性率显著高于中、低增殖型肠化生。结论 提示GST π是一种较好的胃癌前病变标志物 。 Objective To explore the correlation of the expression of glutathione S transferase (GST) π with intestinal metaplasia as well as its proliferative typing, and secretary state of vitriolic mucus in the gastric mucosa. Methods Immunohistochemical method was used to detect the expression of GST π in 167 cases of gastroscopic biopsy of the mucosa or surgical removed gastric specimens. Both mucus histochemical and immunohistochemical methods was applied to identify the subtypes of proliferative activity in 112 cases of chronic atrophy gastritis (CAG) with intestinal metaplasia. Results Expression of GST π was significantly higher in gastric adenocarcinoma and CAG with intestinal metaplasia or/and dysplasia than in chronic superficial gastritis. There was no apparent difference between gastric adenocarcinoma and CAG with dysplasia. Expression of GST π was not related to the secretion of vitriolic mucus in the mucosa with intestinal metaplasia. The positive rate of GST π staining was significantly higher in the high proliferative type (HPT)than in lower and medium proliferative types of CAG with intestinal metaplasia. Conclusions GST π is a good marker for precancerous lesion of the stomach. CAG with HPT is highly correlated with occurrence of gastric cancer.
出处 《诊断病理学杂志》 CSCD 2001年第2期93-95,I029,共4页 Chinese Journal of Diagnostic Pathology
关键词 谷胱甘肽S转移酶 肠化生 增殖细胞核抗原 胃黏膜 GST π Intestinal metaplasia Proliferating cell nuclear antigen Gastric mucosa
  • 相关文献

参考文献9

二级参考文献13

共引文献65

同被引文献24

  • 1王学伟,莫剑忠.胆汁反流与胃黏膜肠化生[J].胃肠病学,2004,9(5):309-311. 被引量:4
  • 2MORGAN R, ADAM A. Use of metallic stents and balloons in the esophagus and gostrointestinal tract [J]. Vosc Interv Radiof, 2001,12: 283-297.
  • 3FOX J G, WANG T C. Inflammation, atrophy, and gastric cancer [J].J Clin Invest, 2007,117 : 60- 69.
  • 4HONDA S, FUJIOKA T, TOKIEDA M, et al. Gastric ulcer, atrophic gastric ulcer, atrophic gastritis, and intestinal metaplasia caused by Helicobacter pylon infection in mongol in gerbils [J]. Stand J Gastroenterol, 1998,33:454--460.
  • 5YAMAMOTO M,TSUKAMOTO T, SAKAI H,et al. p53 knockout mice(-/-)are moresusceptible than (+/--) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis [J].Carcinogenesis, 2000, 21 : 1891-- 1897.
  • 6FUKAMACHI H, ITO K, ITO Y. Runx3^-/- gastric epithelial cells differentiate into intestinal type cells [J]. Biochon Biophys Res Commun,2004,321:58--64.
  • 7LEUNG W K, SUNG J J. Review article: intestinal metaplasia and gastric carcinogenesis [J]. Aliment Pharmacol Ther, 2002,16 : 1209-- 1216.
  • 8ZULLO A, RINALDI V, HASSAN C, et al. Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized study[J]. Aliment Pharmacol Ther,2000,14 : 1303--1309.
  • 9CORREA P, FONTHAM E T H,BRAVO J C, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobaeter therapy [J].Natl Cancer Inst,2000,92: 1881--1888.
  • 10LEUNG W K, NG E K,CHAN F K, et aL Effects of long-term rofecoxib on gastric intestinal metaplasia results of a randomized controlled trial [J]. Clin Cancer Res, 2006,12.4766--4772.

引证文献1

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部